Sweden’s Arcam, a maker of electron beam melting additive manufacturing systems, will move into medical implant manufacturing after its acquisition of DiSanto Technology.
DiSanto was established in 1967 as a medical contract manufacturer and has become a specialist in orthopaedic implants. It employs around 100, according to the release, and was a strategic partner to Arcam since February 2013.
“With this deal we will be part of the leading company in 3D-printing in metals,” said DiSanto’s Ronald F. Dunn.
“This will enable us to help customers in rapidly developing product applications and to commercially produce products for them with Arcam’s cost-efficient, regulatory-cleared Additive Manufacturing technology.”
The deal was worth $US 15.8 million in cash and stock options.
“Through this acquisition Arcam’s offering will cover the entire supply chain for our customers: Metal powders through AP&C, acquired earlier this year, EBM systems and services through Arcam AB and finished products through DiSanto,” said Arcam’s CEO Magnus René.
3DPrint.com notes that this follows several acquisitions by Arcam’s competitor 3D Systems, including in medical technology.
The CSIRO has had an Arcam EBM machine since 2012, able to print in metals and alloys including titanium and cobalt chrome.